Protalix Biotherapeutics Inc (PLX) — Long-term Investment Intensity
Protalix Biotherapeutics Inc (PLX) has a Long-term Investment Intensity of 7.0% as of June 2020. Long-term investments of $5.03 Million represent 7.0% of total assets of $71.71 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Protalix Biotherapeutics Inc shareholders equity for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Annual Long-term Investment Intensity for Protalix Biotherapeutics Inc (None–None)
The table below presents the year-by-year Long-term Investment Intensity for Protalix Biotherapeutics Inc from None to None, covering 0 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Protalix Biotherapeutics Inc (PLX) market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|